LEXTF
Lexston Life Sciences Corp. operates as a biotechnology company that provides cannabis testing and research services in Canada. The company also offers analytical testing for cannabis, pathogens, and toxins. In addition, it focuses on developing and validating methods for standardized manufacturing of plant derived psychedelics in the field of mental health and wellness. The company is based in Vancouver, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.02 | $0 | -$175,463 |
| 2025 Q2 | -0.02 | $0 | -$623,925 |
| 2025 Q1 | -0.04 | $0 | -$155,874 |
| 2025 Q4 | -0.06 | $0 | -$68,430 |
| 2025 Q3 | -0.05 | $0 | -$102,887 |
| 2024 Q2 | -0.08 | $0 | -$634,428 |
| 2024 Q1 | -0.11 | $0 | -$386,997 |
| 2024 Q4 | -0.08 | $0 | -$211,060 |